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Mesenchymal Stem Cell–Encapsulated Collagen
Microspheres for Bone Tissue Engineering
Barbara Pui Chan, Ph.D.,1,2 Ting Yan Hui, M.Phil.,1,2 Mei Yi Wong, B.Eng.,1,2
Kevin Hak Kong Yip, B.D.S., Ph.D.,3 and Godfrey Chi Fung Chan, M.D.4
There is a demonstrated clinical need for alternatives of autologous fresh bone graft with excellent biological
performance in osteoconductivity, osteoinductivity, and osteogenicity. We previously developed a collagen
microencapsulation technology entrapping bone marrow–derived mesenchymal stem cells (MSCs) in a biomi-
metic collagen fiber meshwork and produced injectable collagen–MSC microspheres. In this study, we hy-
pothesize that injectable microspheres with osteoconductivity, osteogenicity, and osteoinductivity can be
fabricated by differentiating the encapsulated MSCs, from either human or mouse sources, toward osteogenic
lineages in these three-dimensional microspheres. The osteogenicity, osteoconductivity, and osteoinductivity of
the microspheres were evaluated in vitro. Osteogenic markers of the differentiating MSCs including alkaline
phosphatase and calcium deposition showed positive staining. Osteoconductivity of the collagen meshwork in
the microsphere was demonstrated by the presence of calcium phosphate deposits among the collagen fibers and
by the significantly increased calcium content extracted from the microspheres. Moreover, osteoinductivity of
the MSC-encapsulated microspheres was demonstrated by the ability to induce osteogenic differentiation of
undifferentiated MSCs in both contact and noncontact coculture. This study contributes toward the future
development of injectable alternatives for fresh bone grafts using autologous MSCs.
Introduction
There is a demonstrated clinical need for alterna-tives of fresh bone grafts in treating bone disorders.1–3
Autologous bone grafts are the gold standard for bone repair
and regeneration.4 This is mainly because of the absence of
immunogenicity and the presence of three favorable char-
acteristics for bone regeneration—namely, osteoinductivity,
osteoconductivity, and osteogenicity.1,3,5 Nevertheless, in-
vasive nature of the harvesting procedure, donor-site mor-
bidities, and limited availability are the main drawbacks of
autologous bone grafting irrespective of the excellent per-
formance of this approach. Allogenic or xenogenic bone grafts
do not have the donor-site morbidity and the availability
issues but present the immunogenicity problem and have
compromised the biological performance as compared to
autografts.6,7
Upon Urist’s initial report on the osteoinductivity of de-
mineralized and freeze-dried allogenic grafts,8 the active com-
pounds responsible for the osteoinductivity, namely, bone
morphogenic proteins (BMPs), have been identified and re-
searched extensively,9,10 and the demineralized bone matrix
possessing osteoinductivity has been developed into various
formulations.2,11 Nevertheless, multiple injections of BMPs
are needed, and better carriers able to control their release
are therefore needed to make them an affordable option. For
the demineralized bone matrix, mechanically stable carriers
and augmentation formulations are needed to improve their
handling capability.2
Osteoconductivity of bone grafts is the ability to provide
three-dimensional (3D) porous structures facilitating cell and
nutrient infiltration for bone growth.1,3 Many biomaterials
with osteoconductivity have been developed as bone graft
substitutes to provide readily available scaffolds facilitating
bone ingrowth.12 Examples include calcium phosphate–
based materials, such as insoluble hydroxyapatites and sol-
uble calcium sulfates,1,12,13 and collagen type I.14 However,
osteoconductive materials alone are of limited applications
as they require osteoinductive supplements and osteogenic
cell sources for bone regeneration.
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Osteogenic activity refers to the provision of bone-forming
cells such as osteoblastic cells from fresh bone grafts or bone
marrow.1,15 Bone marrow–derived mesenchymal stem cells
(MSCs) are multipotent cells able to differentiate into multiple
cell types, including osteogenic lineages16 and therefore can
be used as an osteogenic cell source. Important roles of bone
marrow–derived MSCs treating bone disorders have been
reported.17–19 Moreover, the possibility of using autologous
bone marrow–derived MSCs as the osteogenic cell source
assures better biological performance for bone regeneration.
We previously developed a novel collagen microencapsu-
lation technology,20 which entraps bone marrow MSCs in a
self-assembled biomimetic collagen matrix consisting of col-
lagen fiber meshwork. These stable and injectable micro-
spheres provide a physiologically relevant microenvironment
to support MSC viability, proliferation, migration, and dif-
ferentiation have been produced for cell delivery and tissue
engineering.21 Recently, we successfully induced the encap-
sulated bone marrow MSCs into chondrogenic lineage, which
remodels the fibrous meshwork with cartilage-specific type II
collagen and aggrecan matrix, producing injectable cartilage
tissue micromasses.22 In this study, we hypothesize that in-
jectable microspheres with osteogenic, osteoconductive, and
osteoinductive activities can be fabricated by differentiating
human MSCs (hMSCs) or mouse MSCs (mMSCs) encapsu-
lated in these 3D microspheres toward osteogenic lineages.
Osteogenic markers such as alkaline phosphatase (ALP) and
calcium deposition of the differentiating MSCs will be eval-
uated by cytochemical staining. Osteoconductivity of the
collagen microsphere will be evaluated by microstructural
analysis using scanning electron microscopy (SEM) and en-
ergy dispersive X-ray (EDX) and quantitative calcium content
analysis. Osteoinductivity of the osteogenic differentiated
MSC-encapsulated microspheres will be evaluated by contact
and noncontact coculture with undifferentiated MSCs.
Materials and Methods
Isolation and culture of hMSC
Human bone marrow aspiration and isolation and culture
of hMSCs were conducted as previously described.23 In brief,
bone marrow aspirates were collected from three healthy
donors, in accordance with the protocol approved by the
Combined Clinical Ethics Committee of the University of
Hong Kong and Hong Kong West Cluster Hospitals of Hos-
pital Authority. Mononuclear cells were isolated by a Ficoll–
Hypaque (Amersham Biosciences, Uppsala, Sweden) density
gradient and cultured in growth medium consisting of Dul-
becco’s modified Eagle’s medium–low glucose (DMEM-LG),
10% fetal bovine serum (FBS), 100 U=mL penicillin, 100mg=mL
streptomycin, and 2 mM L-glutamine. Cultures were main-
tained at 378C in a humidified atmosphere with 5% CO2.
MSCs were selected by adherence after 24 h and maintained in
growth medium with replacement every 3–4 days. hMSCs in
P1 to P5 were used. The immunophenotype, self-renewal ca-
pacity, and the multiple differentiating potential of the iso-
lated and cultured hMSCs have been verified previously.21,23
Isolation and culture of mMSC
Animal experimentation was conducted with appropriate
ethics approval according to institutional regulations. In brief,
bone marrow was flushed out from the femurs and tibias of
green fluorescent protein (GFP)-mouse (ICR) using a 30-gauge
needle and collected into a 50 mL centrifuge tube through a cell
strainer. Cell suspensions obtained were centrifuged at 400 g
for 10 min before seeding in T75 culture flasks. DMEM-LG
(Gibco, Carlsbad, CA) supplemented with sodium bicarbon-
ate, 10 mM HEPESs, and 10% FBS was used to culture the cells.
Growth medium was changed after 3 days of culture and re-
plenished every 3–4 days thereafter. mMSCs were sub-
cultured, and cells in P1 were used.
Microencapsulation of MSCs in collagen microspheres
Collagen–MSC microspheres were prepared as previously
described.21 In brief, MSC suspensions at a final concentra-
tion of 5105 cells=mL were mixed with neutralized rat tail
type I collagen solution (BD Biosciences, Bedford, MA) at a
final concentration of 2 mg=mL, unless otherwise specified,
in an ice-bath. Droplets of 2.5 mL were pipetted into 35-mm-
diameter culture dishes covered with ultraviolet-irradiated
parafilm to prevent adhesion of the microsphere to the
substratum. The collagen–MSC mixtures underwent gelation
when incubated at 378C in a humidified atmosphere with 5%
CO2 for 30–45 min.
Osteogenic differentiation of MSC
in collagen microspheres
The microspheres were cultured in DMEM-LG supple-
mented with 10% FBS, 100 nM dexamethasone, 50 mM ascor-
bic acid 2-phosphate, and 10 mM b-glycerophosphate as the
osteogenic differentiation induction medium. To compare the
osteogenic differentiation efficiency between mMSC and
hMSC, in each species, 300 collagen–MSC microspheres were
seeded in a 100-mm-diameter culture dish, in triplicates, and
were maintained in the differentiation induction medium for
14 and 19 days with regular medium replenishment. In a
separate experiment, 100 collagen–mMSC microspheres with
final collagen concentration at 3 mg=mL were produced and
cultured in differentiation medium for 7, 14, and 21 days, in
triplicates, to trace the temporal change in calcium content
over time during differentiation.
Histological and immunohistochemical
analysis for osteogenic markers
Samples were fixed with 4% phosphate buffered saline–
buffered paraformaldehyde and cut into 10mm paraffin and
frozen sections. The sections were stained with hematoxylin
and eosin (H&E) for histological analyses. ALP is an early
marker for osteogenic differentiation. During ALP staining,
magenta solution, the initiator, and TAC buffer (Sigma,
Dorset, United Kingdom) were mixed at a ratio of 1:1:50 in
darkness. Droplets of the substrate reagent were added on
the sections and incubated for 10–60 min. The slides were
then rinsed in distilled water, dehydrated, and mounted. von
Kossa staining was used to reveal the presence of calcium
deposits, a marker for advanced stage of osteogenic differ-
entiation. In brief, sections were incubated with 1% silver
nitrate solution (Sigma) in darkness for 30 min and were ir-
radiated under ultraviolet light for 1 h. Unreacted silver was
removed by incubating with 2% sodium thiosulfate for
5 min. Nuclear fast red was used as a counter stain.
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SEM and EDX for microstructural analysis
To examine the microstructure of the collagen–hMSC mi-
crospheres, samples were processed for SEM analysis. The
microspheres were rinsed with phosphate-buffered saline
and fixed in 2.5% glutaraldehyde for 2 h at 48C. After de-
hydration through a graded series of ethanol, the micro-
spheres were critical point dried and fractured to expose
their cross sections. The microspheres were examined with
SEM coupled with EDX spectrometry (LEO 1530; LEO
Electron Microscopy, Cambridge, UK) for microstructural
analysis and for detection of calcium and phosphorus and
their relative distribution in the samples. The quantities of
these elements were measured, and the calcium to phos-
phorus ratios calculated.
Quantification of calcium content after extraction
Calcium deposits in the collagen meshwork of the micro-
spheres were extracted with 1% trichloroacetic acid for 24 h
before quantification by calcium assay kit (Bioassay Systems,
Hayward, CA, Cat#: DICA-500). In brief, equal volumes of
Reagent A and Reagent B were combined and equilibrated to
room temperature before use. Standard solutions of Ca2þ
(12.5–200 mg=mL) were prepared by serial dilution in distilled
water. An aliquot of 5 mL standards or samples was trans-
ferred into wells of a clear-bottom 96-well plate, and 200mL of
working reagent was added. The mixture was incubated at
room temperature for 3 min before measuring the absorbance
at 612 nm. The amounts of Ca2þ present in the samples were
determined by calibrating against the linear region of the
standard curve.
In vitro osteoinductivity assay
Osteoinductivity refers to the ability to induce differenti-
ation of osteogenic cell sources such as MSCs into osteogenic
lineage and therefore induce bone formation.24 The os-
teoinductive activity of the differentiated microspheres was
evaluated by contact and noncontact coculture with undif-
ferentiated MSCs. In brief, undifferentiated MSCs were see-
ded in the lower chamber of a 24-well Transwell culture
plate (BD Biosciences) at a density of 1.5104 cells=well for
3–4 days. Five hundred osteogenically differentiated micro-
spheres with GFP-mMSCs were placed in the upper chamber
of the transwell for noncontact coculture in duplicates.
Growth medium was supplemented to both the upper and
the lower chambers with regular replenishment every 3 days
for 14 days. In separate 24-well culture dishes (BD Biosci-
ences), undifferentiated MSCs at the same seeding densities
were cultured. Same amount of osteogenically differentiated
microspheres were plated on the monolayer cultures of the
undifferentiated MSCs for contact coculture in duplicates.
Normal growth medium was supplemented and exchanged
regularly. At the end of incubation period of 14 days, ALP
staining for osteogenically differentiated MSCs and von
Kossa staining for calcium deposits were used to evaluate
whether the undifferentiated MSCs were induced to differ-
entiate toward the osteogenic lineages.
Statistical analysis
Data were presented as means with standard deviations.
The normality assumption was verified before conducting
parametric tests. Two-way analysis of variance with ap-
propriate post hoc tests were used to compare the differ-
ences in dry weight and calcium content in different groups
and among different time points. One-way analysis of vari-
ance with linear trend analysis was used to compare the dry
weight and calcium content at different time points during
osteogenic differentiation. SPSS (Chicago, IL) 16.0 was used to
execute the analyses, and the significance level was set at
p< 0.05.
Results
Morphological changes of collagen–MSC microspheres
upon osteogenic differentiation
Figure 1 shows the morphological changes of the collagen
microspheres encapsulating hMSC and mMSC during oste-
ogenic differentiation. In general, microspheres cultured in
normal growth medium contracted continuously over time,
whereas microspheres exposed to osteogenic differentiation
medium maintained their sizes at around 250 mm in diameter
soon after the initial contraction. In collagen–mMSC micro-
spheres, calcium deposits in the form of tiny dark granules
(arrows) were found throughout the microspheres on day 5
under the phase contrast microscopy (right panel, Fig. 1).
Calcium deposition continued and the whole microsphere
becomes dark and opaque as soon as day 8, and the mi-
crospheres further darkened over time. In microspheres with
hMSCs, dark patches (arrows) appeared later than those
with mMSC in the second week (day 13) upon differentia-
tion (left panel, Fig. 1). The microsphere becomes darker in
the third week (day 21), but some regions in the microsphere
were still transparent, leading to inhomogeneous darkness.
Control microspheres without osteogenic differentiation for
both hMSC and mMSC were transparent without obvious
calcium deposits throughout the culture period.
Histological and histochemical analysis
of collagen–MSC microspheres
Figure 2 shows the H&E staining and the von Kossa
staining of collagen–MSC microspheres for both mMSC and
hMSC. H&E staining showed the cell and microsphere
morphology. In brief, microspheres with mMSC showed
hypocellularity with basophilic matrix after osteogenic dif-
ferentiation (Fig. 2B) in comparison with eosinophilic matrix
in control microspheres (Fig. 2A). von Kossa staining showed
the calcium deposition within the microspheres. In brief, the
microsphere was heavily stained brown, suggesting calcium
phosphate deposits (Fig. 2D) in contrast with the negative
staining in control microspheres (Fig. 2C). Microspheres with
hMSCs with (Fig. 2F, H) and without differentiation were
shown (Fig. 2E, G). Some grayish=brownish deposits in von
Kossa staining were found (Fig. 2H) although the signal was
much lower than that of mMSC (Fig. 2D).
SEM analysis of collagen–MSC microspheres
after osteogenic differentiation
During osteogenic differentiation, calcium granules de-
posited within the fiber meshwork. Figure 3 shows the SEM
images of collagen–MSC microspheres. The microstructure
of the undifferentiated microsphere is mainly meshwork of
nanosized collagen fibers (Fig. 3A), confirming our previous
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results.21 Upon osteogenic differentiation, there were nu-
merous granules and flakes (*) deposited on the nanofibrous
meshwork (arrows) of the microsphere with mMSCs (Fig. 3B,
C), and the fiber meshwork was less visible than before as
the fibers were covered by the deposits. Under magnified
views, these granules and flakes were around 200 nm in di-
ameter and intercalated with the collagen fibers (arrows)
(Fig. 3C). In microspheres with hMSCs, there were less cal-
cium deposits and the granules were of much smaller size
(Fig. 3D, E). After calcium extraction, the microstructure of
the microsphere resembled the undifferentiated micro-
spheres with collagen fiber meshwork only and without
calcium granules or flakes (Fig. 3F).
EDX analysis of collagen–MSC microspheres
after osteogenic differentiation
Figure 4 shows the EDX analysis for calcium and phos-
phorus elements in the microspheres. The spectrum of differ-
ent elements present in the microspheres during osteogenic
differentiation showed much higher peak heights for calcium
and phosphorus (Fig. 4A) than those in the control micro-
spheres (Fig. 4D). The result was further confirmed by the
higher intensity of positive signals in the mappings of the
EDX analysis for calcium and phosphorus in differentiated
samples (Fig. 4B, C) than control samples (Fig. 4E, F).
Moreover, the signals for both calcium and phosphorus in
FIG. 1. Phase contrast images of collagen microspheres encapsulating mouse mesenchymal stem cell (mMSC) and human
MSC (hMSC) at different time points during osteogenic differentiation. Left panel: morphology of hMSC-encapsulated
collagen microspheres in osteogenically differentiation and control groups on days 0, 3, 13, and 21 postencapsulation. Right
panel: morphology of mMSC-encapsulated collagen microspheres in osteogenic differentiation and control groups on days 0,
5, 8, and 19 postencapsulation. Magnifications: day 0, 4; all others, 10 (arrows indicate dark calcium deposits in the shape
of granules or patches). Color images available online at www.liebertonline.com=ten.
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the samples were homogeneously distributed throughout the
area inspected. The average calcium and phosphorus content
of the samples and the controls were shown in the lower
panel of Figure 4. Osteogenically differentiated microspheres
contained a higher weight percentage in both elements than
the controls. Nevertheless, the weight percentage results are
not fully quantitative as the composition was affected by
many factors, including the sample thickness and roughness,
which are difficult to control in the microsphere configura-
tion. As a result, quantitative analysis for calcium content
FIG. 2. H&E and von Kossa staining of mMSC- and hMSC-collagen microspheres in osteogenic differentiation and control
groups at 21 days post-differentiation. (A–D): mMSC; (E–H): hMSC; (A, B, E, F): H&E staining; (C, D, G, H): von Kossa
staining; (A, E, C, G): Control group; (B, F, D, H): Osteogenic differentiation group. Color images available online at www
.liebertonline.com=ten.
FIG. 3. Scanning electron microscopy of collagen–MSC microspheres before and after calcium extraction. Scanning electron
microscopy pictures revealed the microstructure of collagen–MSC microspheres before osteogenic differentiation (A) and 21
days after osteogenic differentiation (B, C: mMSC; D, E: hMSC) as well as after calcium extraction (F). Magnification: 50 k
(A, B, F); 200 k (C); 100 k (D); 142 k (E). Asterisk indicates calcium deposits in the shape of flakes or granules; arrows
indicate collagen fibers.
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after complete extraction from the microspheres was con-
ducted separately using a calcium extraction assay.
Extraction of calcium deposits from the microspheres
The dark granules or patches of the osteogenically differ-
entiated collagen–MSC microspheres in Figure 1 are directly
associated with the calcium deposition in the microsphere.
This was demonstrated by the gradual removal of dark
granules or patches of the microsphere during calcium ex-
traction by trichloroacetic acid (Fig. 5). Live GFP mMSCs
were present in the microsphere, and the microsphere is
completely opaque and dark before extraction at time 0.
Upon addition of the acid for extraction, the dark calcium
deposits were extracted in a diffusion-controlled manner
over time, and complete extraction of calcium was observed
within 30 min. The microsphere becomes transparent again
after complete extraction of calcium.
Quantification of calcium deposition
in collagen–MSC microspheres
Figure 6 shows the dry weight and calcium contents
normalized by number and dry weight of microspheres en-
capsulating hMSC or mMSC, in various treatment groups
and at different time points. An increase in microsphere dry
weight indicates increased deposition of new extracellular
matrix including the calcium deposits. An increase in cal-
cium per unit dry weight is a measure of the relative amount
of calcium to the dry weight and is an indicator of the quality
of bone formed. An increase in calcium per microsphere in-
dicates increased osteogenic activity of the differentiating
cells or increased osteogenic cells in each microsphere. In
collagen–hMSC microspheres, the dry weights of micro-
spheres between different treatment groups and at different
time points were not significantly different ( p> 0.05) (Fig.
6A). The percentage dry weight of calcium in differentiated
microspheres ranged from 0.3% to 1.2% comparing with the
minimal values in the control group, but the difference was
still statistically insignificant ( p¼ 0.09) (Fig. 6B). Never-
theless, the calcium per microsphere in differentiated collagen–
hMSC microspheres was statistically significantly different
from the control group ( p¼ 0.025), and the significant dif-
ference was due to the osteogenic differentiation ( p¼ 0.008)
but not due to the time factor ( p> 0.05) (Fig. 6C). In micro-
spheres encapsulating mMSCs, the dry weight of micro-
spheres changed significantly ( p< 0.001) and the difference
was due to both time factor ( p¼ 0.004) and treatment group
( p< 0.001) (Fig. 6D). The percentage of calcium dry weight
in differentiated collagen–mMSC microspheres reached
*22% of the total dry weight (Fig. 6E) and was comparable
to that of the native bone.25,26 The change in the percentage
dry weight was also statistically significant ( p¼ 0.001), and
the difference was due to the effect of treatment group
( p< 0.001) but not the time factor (Fig. 6E). Finally, the cal-
cium per microsphere in collagen–mMSC microsphere was
also significantly changed ( p< 0.001), and the difference was
due to both the time factor ( p¼ 0.005) and the treatment
group ( p< 0.001) (Fig. 6F). The right panel of Figure 6 shows
the temporal change of the dry weight, the calcium per dry
weight, and the calcium per microsphere in collagen–mMSC
FIG. 4. Energy dispersive X-ray analysis on collagen–mMSC microspheres at 21 days postdifferentiation. Comparison
between osteogenic differentiation (A–C) and control (D–F) group was shown in the energy dispersive X-ray spectrum
analysis (A, D), and mappings for calcium (B, E) and phosphorus (C, F). The mean values with standard deviations (SDs) for
the relative composition of calcium and phosphorus in different groups are shown in the lower panel (G).
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FIG. 5. Morphological change of osteogenically differentiated collagen–mMSC microspheres (21 days postdifferentiation)
at different time points (min) during calcium extraction by trichloroacetic acid. Color images available online at www
.liebertonline.com=ten.
FIG. 6. Box plots showing the quantification of calcium deposits in collagen–MSC microspheres. Left panel: dry weight (A)
calcium content per unit dry weight (B) and calcium content per microsphere (C) for collagen–hMSC microspheres in
osteogenic differentiation and control groups. Middle panel: dry weight (D) calcium content per unit dry weight (E) and
calcium content per microsphere (F) for collagen–mMSC microspheres in osteogenic differentiation and control groups. Right
panel: dry weight (G) calcium content per unit dry weight (H) and calcium content per microsphere (I) for collagen–mMSC
microspheres at different time points during osteogenic differentiation.
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microspheres during differentiation. Temporal increase in
dry weight and the normalized calcium content was statis-
tically significant ( p< 0.001) with positive linear trend
( p< 0.001), demonstrating some causal relationship between
the osteogenic differentiation and the calcium deposition.
Post hoc Bonferroni’s tests showed that values at all three
different time points were significantly different from one
another for dry weight ( p< 0.001) and calcium per micro-
sphere ( p 0.001), while for calcium per dry weight, all but
the day 14 and 21 pair showed a significant difference
( p< 0.001).
Osteoinductive activity of osteogenically
differentiated collagen–mMSC microspheres
In coculture of differentiated collagen–GFPþve–mMSC
microspheres (Fig. 7B) and undifferentiated MSCs with cell–
cell contact (Fig. 7A–C), GFPve undifferentiated MSCs were
induced to differentiate toward osteogenic lineage as demon-
strated by the positive ALP staining (pink) in the mono-
layered cultures (Fig. 7A). Positive staining was shown at
sites away from the GFPþve microspheres in the superimposed
images (Fig. 7C). This result demonstrated the osteoindu-
ctivity of the differentiated collagen–mMSC microspheres in a
cell-contact manner. In coculture of differentiated collagen–
mMSC microspheres and undifferentiated MSCs without
cell–cell contact in the transwell assay (Fig. 7D–G), the un-
differentiated MSCs were also induced to differentiate toward
osteogenic lineage. This was demonstrated by the positive
signals of the staining for ALP (pink) and calcium deposits
(gray=dark) in the undifferentiated MSC monolayers (Fig. 7D,
F) in the lower chamber of the transwell plate. Control group
exposed to normal medium without the differentiated colla-
gen–mMSC microspheres showed negative signal in both
staining (Fig. 7E, G). This result demonstrated the os-
teoinductivity of the differentiated collagen–mMSC micro-
spheres in a noncontact manner.
Discussion
This study reports the fabrication of injectable bone-like
microspheres with osteoinductivity, osteoconductivity, and
osteogenicity, suggesting the potential to use them in bone
tissue engineering applications.
Collagen microsphere with nanofibrous meshwork
is an excellent osteoconductive material
Osteoconduction is the process in which the 3D structure
of a substance is conductive for the growth of newly formed
bone.12 Collagen is an attractive osteoconductive material
used in bone tissue engineering as it is one of the native
constituents of bone. In most, if not all, previous studies
using collagen for bone tissue engineering,27–30 premade po-
rous scaffolds have been used and the MSCs were seeded in
these structures after the fabrication. In the current study,
MSCs were suspended in a solution of collagen before the
FIG. 7. Osteoinductive activity of collagen–mMSC microspheres after osteogenic differentiation. Upper panel: contact
coculture of collagen–MSC microspheres (14 days postosteogenic differentiation) and undifferentiated MSCs in monolayers
for 21 days after alkaline phosphatase staining under phase contrast microscopy (A), fluorescence microscopy (B), and
overlay of the images (C). Lower panel: noncontact coculture of osteogenically differentiated collagen–MSC microspheres
and undifferentiated MSCs in monolayers after alkaline phosphatase and von Kossa costaining in experimental (D, F) and
control (E, G) groups. Magnifications: (A–C), 20; (D–G), 10. Color images available online at www.liebertonline.com=ten.
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reconstitution of collagen fiber is initiated. The advantages of
this microencapsulation approach over the traditional cell
seeding approach are (i) even distribution of the encapsu-
lated cells throughout the microsphere, (ii) elimination of the
time-consuming cell-seeding step and the inefficient cell
penetration step, and (iii) optimal collagen fiber density of
the meshwork entrapping the MSCs upon fiber reconstitu-
tion and matrix solidification. Nevertheless, the most im-
portant feature of the collagen microsphere contributing to
osteoconduction should be its nanofibrous microstructure
surrounding the encapsulated cells,21,22 as characterized by
the presence of native collagen D-bands of around 67 nm
width,21 randomly distributed fibers of *45–50 nm in di-
ameter,22 and a network of interconnected fibers with mesh
size of *400 nm.31 On the other hand, only macrostruc-
tures with collagen sheet–like structures and macropores of
*300mm were found in freeze-dried collagen scaffolds in
other groups.27–29
MSC is the source for osteogenicity
of the microspheres
Osteogenicity refers to the ability to form bone via the
supply of bone-forming cells.3 In fresh bone graft, bone
marrow provides the source of osteogenic cells such as os-
teoblastic cells or undifferentiated MSCs. MSC becomes an
attractive cell source for bone tissue engineering because of
their multiple differentiating potential, including osteogenic
lineages,16,17 in addition to other favorable characteristics
such as their availability in adult individuals. In the current
study, bone marrow MSCs from both human and mouse
were entrapped in the osteoconductive collagen fiber mesh-
work and successfully differentiated toward the osteogenical
lineages. Both types of differentiated MSCs deposited in-
creasing amount of calcium phosphate within the collagen
microsphere over time during differentiation. Calcium con-
tent analysis in native bones showed *23% calcium dry
weight in mice25 and 19–26% in human.26 In the current study,
the mean calcium dry weight of the mMSC-encapsulated
microspheres after 21 days of osteogenic differentiation was
*22%, comparable to that of the native bone. This change in
extracellular matrix of the microspheres may also lead to
change in the functional properties of the structures. We
observed significant improvement of mechanical properties,
in terms of reduced elastic modulus, up to *1 GPa in oste-
ogenic differentiated collagen–mMSC microspheres (data not
shown), using a microplate compression method developed
in our laboratory.32 Nevertheless, whether the microplate
method be used to measure the mechanical properties of
hard tissues and whether the mechanical properties of the
osteogenic differentiated microspheres correlate with the
compositional change of the microsphere need further in-
vestigations. For those with hMSCs, although the calcium
dry weight was only 0.64%, constituting a small portion of
the native bone, the differentiated phenotype can still be
demonstrated by the significantly higher calcium content per
microsphere, the positive von Kossa staining for calcium
phosphate, and the presence of calcium deposits in the SEM
analysis. In the same osteogenic differentiation medium us-
ing the same cell density and collagen concentration, hMSCs
in collagen microspheres differentiate toward osteogenic
lineage at a less mature status comparing with mMSCs based
on the significantly less mineralization, suggesting that op-
timization on other factors affecting the differentiation po-
tential of hMSC such as cell density, collagen concentration,
and different differentiation media with supplementation of
other osteoinductive signals such as BMPs may be required.
Osteogenic differentiated collagen–MSC
microspheres are osteoinductive
Osteoinduction refers to a process whereby osteoinductive
substances such as BMPs,9,10 calcium phosphates,3,33 and
collagen14 signal the surrounding stem cells to differentiate
into bone cells rather than other lineages.12,24 In the current
study, soluble osteogenic differentiation–stimulating signals
have been provided to induce the osteogenic differentia-
tion of undifferentiated MSCs encapsulated in the collagen
microspheres. The encapsulated MSCs have committed to
osteogenic lineages. The osteoinductive activities of these
microspheres have been demonstrated through cocultures
with undifferentiated MSCs. As a result, these osteoinductive
microspheres entrapping committed MSCs have the poten-
tial to be transplanted or injected to bone defects to stimulate
bone formation. Moreover, the osteoinductive effects of the
differentiated collagen–MSC microspheres are mediated
through, at least partially, substances or factors secreted by
the differentiating MSCs, because osteogenic differentiation
of the undifferentiated MSCs is evident even in noncontact
coculture where the differentiated microspheres were cul-
tured remotely in the upper chamber of the transwells.
Nevertheless, the source of the osteoinductive substances or
factors may also come from the collagen meshwork, which
might soak or immobilize the factors present in the osteo-
genic differentiation medium during the predifferentiation of
MSCs in the microspheres and then released during the co-
culture period. Although we only showed the osteoinductive
effects in the osteogenic differentiated collagen–mMSC
microspheres in the osteoinductive experiments, ongoing
experiment on immunohistochemical staining of collagen–
hMSC microsphere with BMP-2 preliminarily demonstrated
that collagen–hMSC microspheres subjected to osteogenic
differentiation may also be osteoinductive due to the positive
staining of BMP-2 (data not shown). Nevertheless, the exact
mechanisms of the osteoinductivity of the osteogenic differ-
entiated microspheres with both mMSC and hMSC and the
identity of the secreted bioactive factors deserve further
investigations.
Potential applications of the injectable microspheres
The current microencapsulation system provides inject-
able microspheres with osteoconductive, osteogenic, and
osteoinductive activities. These microspheres can be used as
stable carriers for MSC delivery, and the advantage of de-
livering MSCs, which have already been pushed toward the
osteogenic lineage, rather than undifferentiated MSCs could
be earlier bone regeneration and faster bone formation.
Moreover, apart from autologous source, MSCs can be ob-
tained from allogenic sources. Recently, allogeneic therapy
using MSCs for bone regeneration has been suggested.34 The
current delivery system could be used for delivering allo-
genic cells and as allogeneic bone grafts. Moreover, the in-
jectable microspheres can be excellent adjunct to existing
bone scaffolds to further improve the bone regeneration
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outcomes as they also provide osteogenic and osteoinductive
activities.
Conclusion
This study reports fabrication of potential alternatives of
fresh bone grafts using bone marrow MSC-encapsulated col-
lagen microspheres. Both mMSCs and hMSCs have been
differentiated into osteogenic lineages in 3D collagen micro-
spheres as shown by positive expression of ALP and deposi-
tion of calcium phosphates. The collagen fiber meshwork
facilitates deposition of calcium phosphates, and the calcium
content has been shown significantly increased. Collagen
microspheres with committed MSCs possess osteoinductive
activities as demonstrated by the ability to induce undiffer-
entiated MSCs to commit to osteogenic lineage in both contact
and noncontact coculture. This study contributes to the future
development of bone tissue engineering.
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